KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- EBITDA, 2025
- −$341M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$341M | — |
| 2024 | −$254M | — |
| 2023 | −$162M | — |
| 2022 | −$158M | — |
| 2021 | −$98M | — |
| 2020 | −$45M | — |
| 2019 | −$41M | — |
Kymera Therapeutics, Inc.
$107.39−2.73 (−2.48%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$341M | — |
| 2024 | −$254M | — |
| 2023 | −$162M | — |
| 2022 | −$158M | — |
| 2021 | −$98M | — |
| 2020 | −$45M | — |
| 2019 | −$41M | — |